Role of DNA repair machinery and p53 in the testicular germ cell cancer: A review
2016-01-01 Romano, Fj; Rossetti, S; Conteduca, V; Schepisi, G; Cavaliere, C; Di Franco, R; La Mantia, E; Castaldo, L; Nocerino, F; Ametrano, G; Cappuccio, F; Malzone, G; Montanari, M; Vanacore, D; Quagliariello, V; Piscitelli, R; Pepe, Mf; Berretta, M; D'Aniello, C; Perdonà, S; Muto, P; Botti, G; Ciliberto, G; Veneziani, Bm; De Falco, F; Maiolino, P; Caraglia, M; Montella, M; De Giorgi, U; Facchini, G
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: Results of the Italian Named Patient Programme
2015-01-01 Caffo, O; De Giorgi, U; Fratino, L; Lo Re, G; Basso, U; D'Angelo, A; Donini, M; Verderame, F; Ratta, R; Procopio, G; Campadelli, E; Massari, F; Gasparro, D; Macrini, S; Messina, C; Giordano, M; Alesini, D; Zustovich, F; Fraccon, Ap; Vicario, G; Conteduca, V; Maines, F; Galligioni, E
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer
2016-01-01 Veccia, A; Caffo, O; De Giorgi, U; Di Lorenzo, G; Ortega, C; Scognamiglio, F; Aieta, M; Facchini, G; Mansueto, G; Mattioli, R; Procopio, G; Zagonel, V; D'Angelo, A; Spizzo, G; Bortolus, R; Donini, M; Lo Re, G; Massari, F; Vicario, G; Zucali, Pa; Alesini, D; Bonetti, A; Mucciarini, C; Nicodemo, M; Berruti, A; Fratino, L; Lodde, M; Messina, C; Perin, A; Santini, D; Sava, T; Tucci, M; Basso, U; Maines, F; Burgio, Ls; Galligioni, E
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
2018-01-01 Bravaccini, Sara; Puccetti, Maurizio; Bocchini, Martine; Ravaioli, Sara; Celli, Monica; Scarpi, Emanuela; De Giorgi, Ugo; Tumedei, Maria Maddalena; Raulli, Giandomenico; Cardinale, Loredana; Paganelli, Giovanni
Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors
2005-01-01 De Giorgi, U; Aliberti, C; Benea, G; Conti, M; Marangolo, M.
Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
2017-01-01 Necchi, A; Sonpavde, G; Lo Vullo, S; Giardiello, D; Bamias, A; Crabb, Sj; Harshman, Lc; Bellmunt, J; De Giorgi, U; Sternberg, Cn; Cerbone, L; Ladoire, S; Wong, Yn; Yu, Ey; Chowdhury, S; Niegisch, G; Srinivas, S; Vaishampayan, Un; Pal, Sk; Agarwal, N; Alva, A; Baniel, J; Golshayan, Ar; Morales-Barrera, R; Bowles, Dw; Milowsky, Mi; Theodore, C; Berthold, Dr; Daugaard, G; Sridhar, Ss; Powles, T; Rosenberg, Je; Galsky, Md; Mariani, L
Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger
2015-01-01 Caffo, O; Ortega, C; Di Lorenzo, G; Sava, T; De Giorgi, U; Cavaliere, C; Macrini, S; Spizzo, G; Aieta, M; Messina, C; Tucci, M; Lodde, M; Mansueto, G; Zucali, Pa; Alesini, D; D'Angelo, A; Massari, F; Morelli, F; Procopio, G; Ratta, R; Fratino, L; Lo Re, G; Pegoraro, Mc; Zustovich, F; Vicario, G; Ruatta, F; Federico, P; La Russa, F; Burgio, Sl; Maines, F; Veccia, A; Galligioni, E
Ovarian Sertoli-Leydig cell tumor, endometrioid-like yolk sac tumor, and Y-chromosomal material
2003-01-01 De Giorgi, U; Turci, D; Crisanti, E; Cantù, Mg; Cappellini, A; Marangolo, M
Androgen receptor signaling pathways as a target for breast cancer treatment
2016-01-01 Pietri, E; Conteduca, V; Andreis, D; Massa, I; Melegari, E; Sarti, S; Cecconetto, L; Schirone, A; Bravaccini, S; Serra, P; Fedeli, A; Maltoni, R; Amadori, D; De Giorgi, U; Rocca, A.
Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer
2006-01-01 De Giorgi, U; Giannini, M; Frassineti, L; Kopf, B; Palazzi, S; Giovannini, N; Zumaglini, F; Rosti, G; Emiliani, E; Marangolo, M.
Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer
2014-01-01 De Giorgi, U; Rihawi, K; Aieta, M; Lo Re, G; Sava, T; Masini, C; Baldazzi, V; De Vincenzo, F; Camerini, A; Fornarini, G; Burattini, L; Rosti, G; Moscetti, L; Chiuri, Ve; Luzi Fedeli, S; Ferrari, V; Scarpi, E; Amadori, D; Basso, U.
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
2011-01-01 Giuliano, M; Giordano, A; Jackson, S; Hess, Kr; De Giorgi, U; Mego, M; Handy, Bc; Ueno, Nt; Alvarez, Rh; De Laurentiis, M; De Placido, S; Valero, V; Hortobagyi, Gn; Reuben, Jm; Cristofanilli, M.
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
2018-01-01 Conteduca, V; Scarpi, E; Salvi, S; Casadio, V; Lolli, C; Gurioli, G; Schepisi, G; Wetterskog, D; Farolfi, A; Menna, C; De Lisi, D; Burgio, Sl; Beltran, H; Attard, G; De Giorgi, U
KIT mutations and imatinib dose effects in patients with gastrointestinal stromal tumors
2007-01-01 De Giorgi, U
Plasma AR and abiraterone-resistant prostate cancer
2015-01-01 Romanel, A; Gasi Tandefelt, D; Conteduca, V; Jayaram, A; Casiraghi, N; Wetterskog, D; Salvi, S; Amadori, D; Zafeiriou, Z; Rescigno, P; Bianchini, D; Gurioli, G; Casadio, V; Carreira, S; Goodall, J; Wingate, A; Ferraldeschi, R; Tunariu, N; Flohr, P; De Giorgi, U; de Bono, Js; Demichelis, F; Attard, G
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
2018-01-01 Powles, T; Durán, I; van der Heijden, Ms; Loriot, Y; Vogelzang, Nj; De Giorgi, U; Oudard, S; Retz, Mm; Castellano, D; Bamias, A; Fléchon, A; Gravis, G; Hussain, S; Takano, T; Leng, N; Kadel III, Ee; Banchereau, R; Hegde, Ps; Mariathasan, S; Cui, N; Shen, X; Derleth, Cl; Green, Mc; Ravaud, A
Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone
2015-01-01 Conteduca, V; Caffo, O; Derosa, L; Veccia, A; Petracci, E; Chiuri, Ve; Santoni, M; Santini, D; Fratino, L; Maines, F; Testoni, S; De Giorgi, U
High-dose chemotherapy for adult-type ovarian granulosa cell tumors: a retrospective study of the European Society for Blood and Marrow Transplantation
2017-01-01 De Giorgi, U; Nicolas-Virelizier, E; Badoglio, M; Bader, P; Richard, S; Maertens, J; Lanza, F; Bregni, M
A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer
2015-01-01 Pietri, E; Andreis, D; Fabbri, F; Menna, C; Schirone, A; Kopf, B; Rocca, A; Amadori, D; De Giorgi, U
Circulating tumor cells in metastatic inflammatory breast cancer
2009-01-01 Mego, M; De Giorgi, U; Hsu, L; Ueno, Nt; Valero, V; Jackson, S; Andreopoulou, E; Kau, Sw; Reuben, Jm; Cristofanilli, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Role of DNA repair machinery and p53 in the testicular germ cell cancer: A review | 1-gen-2016 | Romano, Fj; Rossetti, S; Conteduca, V; Schepisi, G; Cavaliere, C; Di Franco, R; La Mantia, E; Castaldo, L; Nocerino, F; Ametrano, G; Cappuccio, F; Malzone, G; Montanari, M; Vanacore, D; Quagliariello, V; Piscitelli, R; Pepe, Mf; Berretta, M; D'Aniello, C; Perdonà, S; Muto, P; Botti, G; Ciliberto, G; Veneziani, Bm; De Falco, F; Maiolino, P; Caraglia, M; Montella, M; De Giorgi, U; Facchini, G | |
| Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: Results of the Italian Named Patient Programme | 1-gen-2015 | Caffo, O; De Giorgi, U; Fratino, L; Lo Re, G; Basso, U; D'Angelo, A; Donini, M; Verderame, F; Ratta, R; Procopio, G; Campadelli, E; Massari, F; Gasparro, D; Macrini, S; Messina, C; Giordano, M; Alesini, D; Zustovich, F; Fraccon, Ap; Vicario, G; Conteduca, V; Maines, F; Galligioni, E | |
| Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer | 1-gen-2016 | Veccia, A; Caffo, O; De Giorgi, U; Di Lorenzo, G; Ortega, C; Scognamiglio, F; Aieta, M; Facchini, G; Mansueto, G; Mattioli, R; Procopio, G; Zagonel, V; D'Angelo, A; Spizzo, G; Bortolus, R; Donini, M; Lo Re, G; Massari, F; Vicario, G; Zucali, Pa; Alesini, D; Bonetti, A; Mucciarini, C; Nicodemo, M; Berruti, A; Fratino, L; Lodde, M; Messina, C; Perin, A; Santini, D; Sava, T; Tucci, M; Basso, U; Maines, F; Burgio, Ls; Galligioni, E | |
| PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis | 1-gen-2018 | Bravaccini, Sara; Puccetti, Maurizio; Bocchini, Martine; Ravaioli, Sara; Celli, Monica; Scarpi, Emanuela; De Giorgi, Ugo; Tumedei, Maria Maddalena; Raulli, Giandomenico; Cardinale, Loredana; Paganelli, Giovanni | |
| Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors | 1-gen-2005 | De Giorgi, U; Aliberti, C; Benea, G; Conti, M; Marangolo, M. | |
| Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC) | 1-gen-2017 | Necchi, A; Sonpavde, G; Lo Vullo, S; Giardiello, D; Bamias, A; Crabb, Sj; Harshman, Lc; Bellmunt, J; De Giorgi, U; Sternberg, Cn; Cerbone, L; Ladoire, S; Wong, Yn; Yu, Ey; Chowdhury, S; Niegisch, G; Srinivas, S; Vaishampayan, Un; Pal, Sk; Agarwal, N; Alva, A; Baniel, J; Golshayan, Ar; Morales-Barrera, R; Bowles, Dw; Milowsky, Mi; Theodore, C; Berthold, Dr; Daugaard, G; Sridhar, Ss; Powles, T; Rosenberg, Je; Galsky, Md; Mariani, L | |
| Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger | 1-gen-2015 | Caffo, O; Ortega, C; Di Lorenzo, G; Sava, T; De Giorgi, U; Cavaliere, C; Macrini, S; Spizzo, G; Aieta, M; Messina, C; Tucci, M; Lodde, M; Mansueto, G; Zucali, Pa; Alesini, D; D'Angelo, A; Massari, F; Morelli, F; Procopio, G; Ratta, R; Fratino, L; Lo Re, G; Pegoraro, Mc; Zustovich, F; Vicario, G; Ruatta, F; Federico, P; La Russa, F; Burgio, Sl; Maines, F; Veccia, A; Galligioni, E | |
| Ovarian Sertoli-Leydig cell tumor, endometrioid-like yolk sac tumor, and Y-chromosomal material | 1-gen-2003 | De Giorgi, U; Turci, D; Crisanti, E; Cantù, Mg; Cappellini, A; Marangolo, M | |
| Androgen receptor signaling pathways as a target for breast cancer treatment | 1-gen-2016 | Pietri, E; Conteduca, V; Andreis, D; Massa, I; Melegari, E; Sarti, S; Cecconetto, L; Schirone, A; Bravaccini, S; Serra, P; Fedeli, A; Maltoni, R; Amadori, D; De Giorgi, U; Rocca, A. | |
| Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer | 1-gen-2006 | De Giorgi, U; Giannini, M; Frassineti, L; Kopf, B; Palazzi, S; Giovannini, N; Zumaglini, F; Rosti, G; Emiliani, E; Marangolo, M. | |
| Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer | 1-gen-2014 | De Giorgi, U; Rihawi, K; Aieta, M; Lo Re, G; Sava, T; Masini, C; Baldazzi, V; De Vincenzo, F; Camerini, A; Fornarini, G; Burattini, L; Rosti, G; Moscetti, L; Chiuri, Ve; Luzi Fedeli, S; Ferrari, V; Scarpi, E; Amadori, D; Basso, U. | |
| Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment | 1-gen-2011 | Giuliano, M; Giordano, A; Jackson, S; Hess, Kr; De Giorgi, U; Mego, M; Handy, Bc; Ueno, Nt; Alvarez, Rh; De Laurentiis, M; De Placido, S; Valero, V; Hortobagyi, Gn; Reuben, Jm; Cristofanilli, M. | |
| Plasma androgen receptor and serum chromogranin A in advanced prostate cancer | 1-gen-2018 | Conteduca, V; Scarpi, E; Salvi, S; Casadio, V; Lolli, C; Gurioli, G; Schepisi, G; Wetterskog, D; Farolfi, A; Menna, C; De Lisi, D; Burgio, Sl; Beltran, H; Attard, G; De Giorgi, U | |
| KIT mutations and imatinib dose effects in patients with gastrointestinal stromal tumors | 1-gen-2007 | De Giorgi, U | |
| Plasma AR and abiraterone-resistant prostate cancer | 1-gen-2015 | Romanel, A; Gasi Tandefelt, D; Conteduca, V; Jayaram, A; Casiraghi, N; Wetterskog, D; Salvi, S; Amadori, D; Zafeiriou, Z; Rescigno, P; Bianchini, D; Gurioli, G; Casadio, V; Carreira, S; Goodall, J; Wingate, A; Ferraldeschi, R; Tunariu, N; Flohr, P; De Giorgi, U; de Bono, Js; Demichelis, F; Attard, G | |
| Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial | 1-gen-2018 | Powles, T; Durán, I; van der Heijden, Ms; Loriot, Y; Vogelzang, Nj; De Giorgi, U; Oudard, S; Retz, Mm; Castellano, D; Bamias, A; Fléchon, A; Gravis, G; Hussain, S; Takano, T; Leng, N; Kadel III, Ee; Banchereau, R; Hegde, Ps; Mariathasan, S; Cui, N; Shen, X; Derleth, Cl; Green, Mc; Ravaud, A | |
| Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone | 1-gen-2015 | Conteduca, V; Caffo, O; Derosa, L; Veccia, A; Petracci, E; Chiuri, Ve; Santoni, M; Santini, D; Fratino, L; Maines, F; Testoni, S; De Giorgi, U | |
| High-dose chemotherapy for adult-type ovarian granulosa cell tumors: a retrospective study of the European Society for Blood and Marrow Transplantation | 1-gen-2017 | De Giorgi, U; Nicolas-Virelizier, E; Badoglio, M; Bader, P; Richard, S; Maertens, J; Lanza, F; Bregni, M | |
| A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer | 1-gen-2015 | Pietri, E; Andreis, D; Fabbri, F; Menna, C; Schirone, A; Kopf, B; Rocca, A; Amadori, D; De Giorgi, U | |
| Circulating tumor cells in metastatic inflammatory breast cancer | 1-gen-2009 | Mego, M; De Giorgi, U; Hsu, L; Ueno, Nt; Valero, V; Jackson, S; Andreopoulou, E; Kau, Sw; Reuben, Jm; Cristofanilli, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 03 Articolo su Rivista38605
Data di pubblicazione
- In corso di stampa43
- 2020 - 202710433
- 2010 - 201913552
- 2000 - 20098692
- 1990 - 19993962
- 1980 - 19891442
- 1970 - 1979447
- 1961 - 196934
Editore
- Elsevier BV:PO Box 211, 1000 AE A...454
- American Institute of Physics:2 H...272
- Giuffre Editore Spa:via Busto Ars...128
- Elsevier Science Limited:Oxford F...99
- Congedo Editore Luogo pubbl. Gal...72
- IOP Publishing Limited:Dirac Hous...71
- Springer Verlag Germany:Tiergarte...71
- Kluwer Academic Publishers:Journa...54
- IEEE / Institute of Electrical an...47
- Societa Editrice il Mulino Spa:St...43
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS481
- THE EUROPEAN PHYSICAL JOURNAL. C,...393
- PHYSICS LETTERS. SECTION B392
- PHYSICAL REVIEW LETTERS211
- APPLIED PHYSICS LETTERS186
- NUCLEAR INSTRUMENTS AND METHODS I...185
- THE ASTROPHYSICAL JOURNAL180
- PHYSICAL REVIEW D, PARTICLES, FIE...156
- PHYSICAL REVIEW D148
- ITINERARI DI RICERCA STORICA140
Keyword
- ATLAS1158
- LHC1151
- High Energy Physics1130
- Humans376
- Mediterranean Sea185
- Italy177
- Female144
- Animals143
- Male127
- Hadron-Hadron Scattering122
Lingua
- eng25985
- ita9002
- fre415
- spa191
- ger146
- por94
- lat51
- grc47
- rus43
- chi13
Accesso al fulltext
- no fulltext32279
- open4081
- restricted1185
- reserved1012
- partially open32
- mixed10
- embargoed6